Health Products

Hycodan Tablets (2014-03-03)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
KNPP
Recalling Firm
Bristol-Myers Squibb Canada
2344 Alfred-Nobel, Suite 300
Saint-Laurent
H4S 0A4
Quebec
CANADA
Marketing Authorization Holder
Bristol-Myers Squibb Canada
2344 Alfred-Nobel, Suite 300
Saint-Laurent
H4S 0A4
Quebec
CANADA
A. Hycodan TabletsTabletsDIN 019165995 mg

Introduction

Recalled products

Hycodan Tablets

Reason

Lot KNPP did not meet dissolution specifications at the 12-month stability test point, and there is a risk that lot FSTN may not meet dissolution specifications at the end of shelf-life.

Depth of distribution

Wholesalers across Canada
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime